Literature DB >> 17869134

Antigen crosspresentation by human plasmacytoid dendritic cells.

Guillaume Hoeffel1, Anne-Claire Ripoche, Diana Matheoud, Michelina Nascimbeni, Nicolas Escriou, Pierre Lebon, Farhad Heshmati, Jean-Gérard Guillet, Monique Gannagé, Sophie Caillat-Zucman, Nicoletta Casartelli, Olivier Schwartz, Henri De la Salle, Daniel Hanau, Anne Hosmalin, Concepción Marañón.   

Abstract

Crosspresentation is a specialized function of myeloid dendritic cells (mDCs), allowing them to induce CD8+ T cell responses against exogenous antigens that are not directly produced in their cytotosol. Human plasmacytoid DCs (pDCs) are not considered so far as able to perform crosspresentation. We showed here that purified human pDCs crosspresented vaccinal lipopeptides and HIV-1 antigens from apoptotic cells to specific CD8+ T lymphocytes. Apoptotic debris were internalized by phagocytosis and the lipopeptide LPPol reached nonacidic endosomes. This crosspresentation was amplified upon influenza virus infection. Importantly, the efficiency of crosspresentation by pDCs was comparable to that of mDCs. This property of human pDCs needs to be taken into account to understand the pathogenesis of infectious, allergic, or autimmune diseases and to help achieve desired responses during vaccination by targeting specifically either type of DCs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17869134     DOI: 10.1016/j.immuni.2007.07.021

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  108 in total

Review 1.  Dendritic cells and aging: consequences for autoimmunity.

Authors:  Anshu Agrawal; Aishwarya Sridharan; Sangeetha Prakash; Harsh Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2012-01       Impact factor: 4.473

Review 2.  Dynamics of dendritic cell-T cell interactions: a role in T cell outcome.

Authors:  Stéphanie Hugues
Journal:  Semin Immunopathol       Date:  2010-07-06       Impact factor: 9.623

3.  Prolonged antigen storage endows merocytic dendritic cells with enhanced capacity to prime anti-tumor responses in tumor-bearing mice.

Authors:  Rachel A Reboulet; Cassandra M Hennies; Zacarias Garcia; Stefan Nierkens; Edith M Janssen
Journal:  J Immunol       Date:  2010-08-18       Impact factor: 5.422

4.  A CpG-loaded tumor cell vaccine induces antitumor CD4+ T cells that are effective in adoptive therapy for large and established tumors.

Authors:  Matthew J Goldstein; Bindu Varghese; Joshua D Brody; Ranjani Rajapaksa; Holbrook Kohrt; Debra K Czerwinski; Shoshana Levy; Ronald Levy
Journal:  Blood       Date:  2010-09-27       Impact factor: 22.113

5.  Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation.

Authors:  Juliette Mouriès; Gabriel Moron; Géraldine Schlecht; Nicolas Escriou; Gilles Dadaglio; Claude Leclerc
Journal:  Blood       Date:  2008-08-12       Impact factor: 22.113

6.  In vivo ablation of plasmacytoid dendritic cells inhibits autoimmunity through expansion of myeloid-derived suppressor cells.

Authors:  Marianna Ioannou; Themis Alissafi; Louis Boon; Dimitrios Boumpas; Panayotis Verginis
Journal:  J Immunol       Date:  2013-02-04       Impact factor: 5.422

7.  Role for plasmacytoid dendritic cells in the immune control of recurrent human herpes simplex virus infection.

Authors:  Heather Donaghy; Lidija Bosnjak; Andrew N Harman; Valerie Marsden; Stephen K Tyring; Tze-Chiang Meng; Anthony L Cunningham
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

Review 8.  The plasmacytoid dendritic cell as the Swiss army knife of the immune system: molecular regulation of its multifaceted functions.

Authors:  Julien J Karrich; Loes C M Jachimowski; Christel H Uittenbogaart; Bianca Blom
Journal:  J Immunol       Date:  2014-12-15       Impact factor: 5.422

9.  Systemic dendritic cell mobilization associated with administration of FLT3 ligand to SIV- and SHIV-infected macaques.

Authors:  R Keith Reeves; Qing Wei; Jackie Stallworth; Patricia N Fultz
Journal:  AIDS Res Hum Retroviruses       Date:  2009-12       Impact factor: 2.205

Review 10.  Cross-presentation of IgG-containing immune complexes.

Authors:  Kristi Baker; Timo Rath; Wayne I Lencer; Edda Fiebiger; Richard S Blumberg
Journal:  Cell Mol Life Sci       Date:  2012-07-31       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.